BHVN
Biohaven Pharmaceutical Holding Company Ltd
Price:  
42.59 
USD
Volume:  
654,134.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BHVN Probability of Bankruptcy

The Probability of Bankruptcy of Biohaven Pharmaceutical Holding Company Ltd (BHVN) is 10.81% . This number represents the probability that BHVN will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating BHVN's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

BHVN - ESG ratings

ESG ratings are directly linked to the cost of capital and BHVN's ability to raise funding, both of which can significantly affect the probability of Biohaven Pharmaceutical Holding Company Ltd going bankrupt.

ESG Score 63.87
Environment Score 35.58
Social Score 99.00
Governance Score 57.04
Returns
Historical Returns (5 day) -0.98%
Historical Returns (MTD) -6.00%
Historical Returns (YTD) 1.05%
Historical Returns (13 week) 18.88%
Historical Returns (26 week) 24.25%
Historical Returns (52 week) 30.82%
Efficiency
Asset Turnover
Receiveable Turnover
Gross Margin
Operating Margin
Pretax Margin
Net Margin
Return on Asset (ROA) -158.89
Return on Equity (ROE) -225.12
Return on Investments (ROI) -225.12
Price Metrics
Market Cap (M) 4,306.70
Enterprise Value (M)
52 Week High 62.21
52 Week Low 26.80
Beta 1.91
Average Volume (10 day) 0.25
Average Volume (3 month) 0.84
Price / Earnings (P/E)
Price / Sales (P/S)
Earnings
EPS -9.35
Revenue CAGR (5 year)
Risk
Current Ratio 2.89
Quick Ratio 2.53